NASDAQ: NLTX - Neoleukin Therapeutics, Inc.

Lønnsomhet i seks måneder: 0%
Sektor: Healthcare

Kampanjeplan Neoleukin Therapeutics, Inc.

Avansert tidsplan Enkel graf
Financial Markets by TradingView

Om selskapet

Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of various types of cancer, including renal cell carcinoma and melanoma. The company was formerly known as Aquinox Pharmaceuticals, Inc. and changed its name to Neoleukin Therapeutics, Inc. in August 2019. Neoleukin Therapeutics, Inc.

flere detaljer
was founded in 2003 and is headquartered in Seattle, Washington.
Legg til i sammenligningslisten
Legg til overvåkningsliste
Legg til portefølje
Legg til prisvarsel

IPO date 2014-03-07
ISIN US64049K1043
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.neoleukin.com
Цена ао 15.1
Prisendring per dag: 0% (15.1)
Prisendring per uke: 0% (15.1)
Prisendring per måned: 0% (15.1)
Prisendring over 3 måneder: 0% (15.1)
Prisendring over seks måneder: 0% (15.1)
Prisendring per år: 0% (15.1)
Prisendring over 3 år: +197.24% (5.08)
Prisendring over 5 år: +335.16% (3.47)
Prisendring over 10 år: 0% (15.1)
Prisendring siden begynnelsen av året: 0% (15.1)
Alle parametere

Undervurdering

Navn Betydning Karakter
P/S 0 0
P/BV 0.2535 10
P/E 0 0
EV/EBITDA 0.0337 10
Total: 5

Effektivitet

Navn Betydning Karakter
ROA, % -40.13 0
ROE, % -47.23 0
Total: 0

Utbytte

Navn Betydning Karakter
Div yield, % 0 0
DSI 0 0
Total: 0

Plikt

Navn Betydning Karakter
Debt/EBITDA -0.2142 10
Total: 10

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % -98.2 0
Lønnsomhet Ebitda, % 78.75 8
Lønnsomhet EPS, % -72.37 0
Total: 4.6
Flere detaljer

Institusjoner Volum Dele, %
Baker Brothers Advisors, LLC 1221414 13
Redmile Group, LLC 582443 6.2
Adage Capital Partners GP L.L.C. 310000 3.3
Nantahala Capital Management, LLC 299999 3.19
Bank of America Corporation 231779 2.47
Vanguard Group Inc 201539 2.14
Renaissance Technologies, LLC 163447 1.74
Morgan Stanley 107671 1.15
Bml Capital Management, LLC 98664 1.05
Blackrock Inc. 96613 1.03



Veileder Stillingstittel Betaling Fødselsår
Ms. Donna M. Cochener-Metcalfe J.D. Gen. Counsel & Sr. VP of Legal 403.75k 1975 (50 år)
Mr. Sean Michael Smith Principal Accounting Officer, VP of Fin. & Controller N/A 1986 (39 år)
Dr. Jonathan G. Drachman M.D. CEO, Pres, Principal Financial Officer & Director 1962 (63 år)
Dr. Priti Patel M.D., M.S. Chief Medical Officer 1976 (49 år)
Dr. David Baker Co-founder & Member of Scientific Advisory Board
Dr. Carl Walkey Ph.D. Sr. VP of Corp. Devel. 1985 (40 år)
Mr. Kamran Alam Sr. Strategic Advisor 1974 (51 år)
Dr. Bill Arthur VP & Head of Research
Mr. Umut Ulge VP of Clinical Devel.

Adresse: United States, Seattle. WA, 188 East Blaine Street - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.neoleukin.com